News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,234 Results
Type
Article (39688)
Company Profile (247)
Press Release (658299)
Multimedia
Podcasts (48)
Webinars (12)
Section
Business (204231)
Career Advice (2009)
Deals (35429)
Drug Delivery (95)
Drug Development (81036)
Employer Resources (172)
FDA (16175)
Job Trends (14855)
News (345246)
Policy (32532)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2555)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49470)
ALS (87)
Alzheimer's disease (1372)
Antibody-drug conjugate (ADC) (122)
Approvals (16177)
Artificial intelligence (246)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11637)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (66)
Brain cancer (26)
Breast cancer (271)
Cancer (2165)
Cardiovascular disease (170)
Career advice (1677)
Career pathing (30)
CAR-T (145)
Cell therapy (406)
Cervical cancer (19)
Clinical research (65910)
Collaboration (814)
Compensation (519)
Complete response letters (19)
COVID-19 (2584)
CRISPR (37)
C-suite (231)
Cystic fibrosis (100)
Data (2094)
Decentralized trials (2)
Denatured (18)
Depression (41)
Diabetes (263)
Diagnostics (6361)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (92)
Earnings (86457)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112123)
Executive appointments (706)
FDA (17387)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (741)
Gene editing (100)
Generative AI (19)
Gene therapy (287)
GLP-1 (703)
Government (4411)
Grass and pollen (4)
Guidances (52)
Healthcare (18814)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (112)
Indications (28)
Infectious disease (2726)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (92)
Interviews (312)
IPO (16507)
IRA (40)
Job creations (3630)
Job search strategy (1423)
Kidney cancer (10)
Labor market (38)
Layoffs (462)
Leadership (16)
Legal (7909)
Liver cancer (73)
Lung cancer (311)
Lymphoma (147)
Machine learning (6)
Management (58)
Manufacturing (295)
MASH (65)
Medical device (13360)
Medtech (13365)
Mergers & acquisitions (19450)
Metabolic disorders (669)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (27)
Neuroscience (1887)
NextGen: Class of 2025 (6513)
Non-profit (4477)
Northern California (2598)
Now hiring (39)
Obesity (358)
Opinion (204)
Ovarian cancer (73)
Pain (81)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (227)
Patient recruitment (105)
Peanut (46)
People (57262)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20526)
Phase II (29023)
Phase III (21629)
Pipeline (1139)
Policy (135)
Postmarket research (2563)
Preclinical (8691)
Press Release (64)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (373)
Real estate (5906)
Recruiting (65)
Regulatory (22233)
Reports (46)
Research institute (2320)
Resumes & cover letters (351)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (66)
Series A (128)
Series B (83)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2230)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3578)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (33)
The Weekly (28)
United States (22452)
Vaccines (676)
Venture capitalists (41)
Weight loss (231)
Women's health (35)
Worklife (15)
Date
Last 7 days (640)
Last 30 days (2241)
Last 365 days (32674)
2025 (9842)
2024 (35219)
2023 (40077)
2022 (51177)
2021 (55720)
2020 (54106)
2019 (46547)
2018 (35028)
2017 (32116)
2016 (31486)
2015 (37558)
2014 (31327)
2013 (26358)
2012 (28585)
2011 (29280)
2010 (27354)
Location
Africa (719)
Alabama (52)
Alaska (7)
Arizona (230)
Arkansas (13)
Asia (37813)
Australia (6182)
California (5928)
Canada (1969)
China (503)
Colorado (260)
Connecticut (265)
Delaware (139)
Europe (81221)
Florida (878)
Georgia (202)
Idaho (57)
Illinois (519)
India (25)
Indiana (305)
Iowa (11)
Japan (157)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (870)
Massachusetts (4418)
Michigan (216)
Minnesota (384)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1679)
New Mexico (28)
New York (1687)
North Carolina (950)
North Dakota (7)
Northern California (2598)
Ohio (199)
Oklahoma (14)
Oregon (34)
Pennsylvania (1335)
Puerto Rico (11)
Rhode Island (32)
South America (1097)
South Carolina (22)
South Dakota (1)
Southern California (2230)
Tennessee (101)
Texas (879)
Utah (177)
Virginia (140)
Washington D.C. (61)
Washington State (543)
West Virginia (3)
Wisconsin (52)
698,234 Results for "microarrays inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) multiplex microarray
April 3, 2025
·
4 min read
Press Releases
Vaxxas Completes Enrollment for Largest Clinical Trial of High-Density Microarray Patch (HD-MAP) For Vaccine Delivery
February 18, 2025
·
6 min read
Press Releases
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray
February 10, 2025
·
4 min read
Press Releases
Newly Published Data Supports Effective Delivery of DNA-Based Vaccines Using Vaxxas’ High-Density Microarray Patch (HD-MAP) Delivery Technology
March 5, 2025
·
8 min read
Biotech Beach
Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping
Bionano Genomics, Inc. announced a publication covering the largest independent prospective prenatal study comparing optical genome mapping to a combined workflow of chromosomal microarray analysis and karyotyping.
December 26, 2023
·
7 min read
Deals
Spectrum Solutions Acquires Alimetrix, Inc. and Microarrays, Inc. to Expand Laboratory Products and Testing Capabilities
Spectrum Solutions ® today announced the acquisitions of Alimetrix, Inc. and Microarrays, Inc.
March 7, 2023
·
2 min read
Press Releases
DNA Microarray Market Size to Grow approximately USD 6.13 Bn by 2034
October 14, 2024
·
1 min read
Press Releases
Microarray Market Size is Expected to Reach USD 13.81 Billion by 2034
July 30, 2024
·
8 min read
Press Releases
AliveDx Receives IVDR CE Mark for Groundbreaking Microarray Immunoassay in Allergy Diagnostics
July 29, 2024
·
3 min read
Biotech Beach
Thermo Fisher Scientific Introduces New Chromosomal Microarray with Two-Day Turnaround Time to Increase Lab Productivity
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day turnaround time.
August 22, 2023
·
3 min read
1 of 69,824
Next
